Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial
Research article
[키워드] 1:1
95% CI
analyses
Analysis
BCG
BCG vaccination
Breastfeeding
Cape
Capital
childhood
computation
computing
Council
COVID-19
COVID-19 testing
died
Donor
double-blind
Dream
Efficacy
enrolled
Epigenetic
evaluated
Evidence
female
finding
FIVE
foundation
functional
funding
had no
hazard ratio
healthcare
healthcare worker
hospitalisation
hypersensitivity
hypothesised
Immunocompromised
Infrastructure
innate immune system
introduced
Investment
IQR
median age
medical doctors
morbidity
morbidity and mortality
non-specific
Nurses
occurred
pandemic
participant
phase 3 trial
placebo-controlled trial
pregnant
Prevent
PROTECT
provided
randomised
recruited
reduction
Registered
resource
respiratory tract infection
Respiratory tract infections
Safety
SARS-CoV-2
SARS-COV-2 infection
severe COVID-19 disease
severity
South Africa
statistically significant
Swedish
Symptoms
the placebo group
trained immunity
Treatment
Tuberculosis
Vaccine
were assessed
[DOI] 10.1016/j.eclinm.2022.101414 [Article Type] Research article
[DOI] 10.1016/j.eclinm.2022.101414 [Article Type] Research article